TN2010000394A1 - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
TN2010000394A1
TN2010000394A1 TNP2010000394A TN2010000394A TN2010000394A1 TN 2010000394 A1 TN2010000394 A1 TN 2010000394A1 TN P2010000394 A TNP2010000394 A TN P2010000394A TN 2010000394 A TN2010000394 A TN 2010000394A TN 2010000394 A1 TN2010000394 A1 TN 2010000394A1
Authority
TN
Tunisia
Prior art keywords
pharmaceutical composition
stability
solubility
mentioned compound
water
Prior art date
Application number
TNP2010000394A
Other languages
French (fr)
Inventor
Tomomichi Futo
Shinichiro Nakai
Jong Rinaldo Laurentius De
Bumsup Lee
Ronald Joseph Christopher
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/JP2009/054237 external-priority patent/WO2009107877A1/en
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of TN2010000394A1 publication Critical patent/TN2010000394A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention provides a pharmaceutical composition, wherein solubility and stability of a water-insoluble or slightly water-soluble compound represented by formula (1): wherein each symbol is as defined in the specification, are improved, by combination of the above-mentioned compound and a cyclodextrin derivative and a method for improving solubility, stability and the like of the above-mentioned compound.
TNP2010000394A 2009-02-27 2010-08-26 Pharmaceutical composition TN2010000394A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/JP2009/054237 WO2009107877A1 (en) 2008-02-28 2009-02-27 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
TN2010000394A1 true TN2010000394A1 (en) 2011-12-29

Family

ID=55024516

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2010000394A TN2010000394A1 (en) 2009-02-27 2010-08-26 Pharmaceutical composition

Country Status (1)

Country Link
TN (1) TN2010000394A1 (en)

Similar Documents

Publication Publication Date Title
EP2477985A4 (en) Treatment of cancer
TW200801000A (en) Spiroindolinone derivatives
WO2008009831A3 (en) Novel amphiphilic cyclodextrin derivatives
NZ588884A (en) Cross-linkers and their uses
MY153915A (en) Organic compounds
BR112012011328A2 (en) akt inhibitors
UA95644C2 (en) Pyridizinone derivative, pharmaceutical composition and treatment method
MX2009007713A (en) Pyridazine derivatives, processes for their preparation and their use as fungicides.
GEP20156242B (en) 2-arylimidazole derivatives as pde10a enzyme inhibitors
WO2011056511A3 (en) 4,6-diaminopyrimidine stimulators of soluble guanylate cyclase
UA96994C2 (en) Derivatives of 7-alkynyl-1,8-naphthyridones, method of the preparation and use thereof
MX2012006805A (en) Indolyl-piperidinyl benzylamines as beta-tryptase inhibitors.
WO2012075117A3 (en) Small molecule-polymer conjugates and methods of making same
EP2131849A4 (en) Compositions and methods for delivery of anti-cancer agents
MX2010009513A (en) Pharmaceutical composition.
NZ594186A (en) Indole derivatives as anticancer agents
TN2012000105A1 (en) Spirolactam derivatives and uses of same
UA104420C2 (en) Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-arrhythmic agents
WO2010077730A3 (en) Indanone inhibitors of acetylcholinesterase
MX2009003459A (en) 2, 3, 3 -trimethylcyclopent-3 -enecarbaldehyde derivatives useful as odorants.
MX2009008249A (en) Pharmaceutical composition comprising a campothecin derivative.
MX347677B (en) Pharmaceutical composition comprising jasmonates.
UA109460C2 (en) N-hetarylmethyl pyrazolylcarboxamides
NZ591837A (en) Amino acid derivative
MY150428A (en) Tricyclic n-heteroaryl-carboxamide derivatives, preparation thereof and therapeutic use of same